Detalles de la búsqueda
1.
Carcinoid Heart Disease: Prognostic Value of 5-Hydroxyindoleacetic Acid Levels and Impact on Survival: A Systematic Literature Review.
Neuroendocrinology;
111(1-2): 1-15, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32097914
2.
Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index.
Neuroendocrinology;
111(9): 850-862, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32911478
3.
Quality-adjusted survival with first-line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance).
Cancer;
126(24): 5311-5318, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33022096
4.
Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study.
Scand J Gastroenterol;
53(12): 1509-1518, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30449217
5.
Cost-effectiveness evaluation in Sweden of escitalopram compared with venlafaxine extended-release as first-line treatment in major depressive disorder.
Value Health;
15(2): 231-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22433753
6.
Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison.
Adv Ther;
38(5): 2472-2490, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33822328
7.
A Budget Impact Model of the Addition of Telotristat Ethyl Treatment to the Standard of Care in Patients with Uncontrolled Carcinoid Syndrome.
Pharmacoeconomics;
38(6): 607-618, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32157590
8.
Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma.
Adv Ther;
37(6): 2678-2695, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32424805
9.
Cabozantinib Versus Standard-of-Care Comparators in the Treatment of Advanced/Metastatic Renal Cell Carcinoma in Treatment-naïve Patients: a Systematic Review and Network Meta-Analysis.
Target Oncol;
13(2): 205-216, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29492762
10.
Relationship Between Symptoms and Health-related Quality-of-life Benefits in Patients With Carcinoid Syndrome: Post Hoc Analyses From TELESTAR.
Clin Ther;
40(12): 2006-2020.e2, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30477789
11.
Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.
J Clin Oncol;
36(8): 757-764, 2018 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29377755
12.
Cost-effectiveness of escitalopram in major depressive disorder in the Dutch health care setting.
Clin Ther;
34(6): 1364-78, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22578310
13.
Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse.
J Clin Psychiatry;
71(6): 784-92, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20492845
14.
Cost effectiveness of escitalopram versus SNRIs in second-step treatment of major depressive disorder in Sweden.
J Med Econ;
13(3): 516-26, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20698748
Resultados
1 -
14
de 14
1
Próxima >
>>